AngioInsight, Inc.
StreetZero Signal 68
About AngioInsight, Inc.
AngioInsight, Inc. is a medical software developer founded in 2018 and headquartered in Minnetonka, Minnesota. The company provides AI-based software for cardiologists to process angiographic images, with its flagship product AngioAI+. It has raised a total of $25.26M across three rounds, including a $25M Series A completed in October 2025. The company is privately held and operates in the biotechnology research and healthcare AI sector.
LATEST FUNDINGSeries A
$16.3M
Announced 2026-11-10
TOTAL RAISED$25.26M
IN THE NEWS
- ๐ AngioInsight - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- ๐ AngioInsight Stock Price, Funding, Valuation, Revenue & Financial Statements
- ๐ AngioInsight raises $25M to launch AngioAI+ - Minneapolis / St. Paul Business Journal
- ๐ AngioInsight, Inc.
- ๐ AngioInsight - 2026 Funding Rounds & List of Investors - Tracxn
EMPLOYEESโ
FOUNDED2018
HQMinnetonka, Minnesota, United States
Industry
Other Health Care
Tags
AIHealthcareMedical ImagingSeries A
Investors
Key highlights
- Completed $25M Series A in October 2025 to launch AngioAI+.
- Added former Johnson & Johnson medtech executive to the board during the round.
- Total funding reached $25.26M across three rounds including grants and seed activity.
- Focuses on AI software for processing angiographic images in cardiology.
Ask StreetZero about AngioInsight, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account